Androgen level variations, clinical response to LHRH agonists and changes in the quality of life subscales in metastatic prostate cancer--speculations about possible role of the monoamine system.

Source:http://linkedlifedata.com/resource/pubmed/id/9473791

Download in:

View as

General Info

PMID
9473791